ArticleCancer drug resistance (Alhambra, Calif.)2022

Approaches to identifying drug resistance mechanisms to clinically relevant treatments in childhood rhabdomyosarcoma.

Samson Ghilu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.